OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
August 03, 2021
Dosage form priorities are shifting to focus on user-friendliness, leading to greater engagement with outsourcing partners earlier in development timelines.
August 02, 2021
Collaborative partnerships can foster success in formulation development projects.
August 01, 2021
The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.
The CRO market will see greater consolidation by both financial buyers looking to consolidate smaller players and larger CRO players wanting to expand into value-added specialty service areas.
June 24, 2021
The companies will utilize the Cocoon Platform for clinical point-of-care manufacturing.
The companies have entered into an agreement to develop processes for a novel immunotherapy protein.
June 22, 2021
Vectura has signed an agreement with Incannex Healthcare for the pre-clinical development of IHL-216A, an inhaled drug product for the treatment of traumatic brain injury.
Thought and foresight into method development stages can ensure costly errors and delays are avoided later on.
June 02, 2021
Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.
March 18, 2021
An integrated CMC provider can help smaller companies to streamline development timelines and reduce project management complexity when compared with multi-provider models.